FXYD3 antibody
Principal name
FXYD3 antibody
Alternative names for FXYD3 antibody
Mammary tumor 8 kDa protein, Phospholemman-like, MAT8, PLML, FXYD domain-containing ion transport regulator 3, Chloride conductance inducer protein Mat-8
Ncbi ID
9606, NP_001129479.1, NM_021910, NM_005971, NM_001136011, NM_001136012, NP_005962, NP_001129483, NP_001129484, NP_032583.1, BC051033, BC002039, NM_008557, NM_172317, NM_001136008, NM_001136009, NM_001136010
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection)), Flow Cytometry (F), Immunocytochemistry/Immunofluorescence (ICC/IF), Paraffin Sections (P)
Background of FXYD3 antibody
- Kit Component:
- - KN306193G1, Fxyd3 gRNA vector 1 in pCas-Guide vector
- KN306193G2, Fxyd3 gRNA vector 2 in pCas-Guide vector
- KN306193D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
FXYD3 polyclonal antibody (A01), Lot # ISI4060209QCS1 Western Blot analysis of FXYD3 expression in A-431 ( Cat # L015V1 ).
Western Blot analysis of FXYD3 expression in transfected 293T cell line (H00005349-T01) by FXYD3 MaxPab polyclonal antibody.Lane 1: FXYD3 transfected lysate(9.68 KDa).Lane 2: Non-transfected lysate.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FXYD3 (RC213945, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FXYD3.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FXYD3 (RC213945, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FXYD3.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FXYD3 (RC213945, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FXYD3.
Anti-FXYD3 mouse monoclonal antibody (TA504610) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY FXYD3(RC213945).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FXYD3 (RC213945, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FXYD3.
Flow cytometric Analysis of Jurkat cells, using anti-FXYD3 antibody(TA504610),(Red), compared to a nonspecific negative control antibody,(Blue).
Immunohistochemical staining of paraffin-embedded Human prostate tissue within the normal limits using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504620)
Immunohistochemical staining of paraffin-embedded Human colon tissue within the normal limits using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504620)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504620)
Immunohistochemical staining of paraffin-embedded Human liver tissue within the normal limits using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504620)
Immunohistochemical staining of paraffin-embedded Carcinoma of Human prostate tissue using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504620)
Immunohistochemical staining of paraffin-embedded Human bladder tissue within the normal limits using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504620)
Anti-FXYD3 mouse monoclonal antibody (TA504620) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY FXYD3(RC213945).
Western blot analysis of extracts (35ug) from 9 different cell lines by usin g anti-FXYD3 monoclonal antibody (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FXYD3 (RC213945, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FXYD3.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FXYD3 (RC213945, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FXYD3.
Immunohistochemical staining of paraffin-embedded Carcinoma of Human prostate tissue using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504717)
Immunohistochemical staining of paraffin-embedded Human colon tissue within the normal limits using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504717)
Immunohistochemical staining of paraffin-embedded Human Kidney tissue within the normal limits using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504717)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504717)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504717)
Immunohistochemical staining of paraffin-embedded Human pancreas tissue within the normal limits using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504717)
Immunohistochemical staining of paraffin-embedded Human tonsil within the normal limits using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504717)
Immunohistochemical staining of paraffin-embedded Carcinoma of Human bladder tissue using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504717)
Immunohistochemical staining of paraffin-embedded Human prostate tissue within the normal limits using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504717)
Immunohistochemical staining of paraffin-embedded Human lymphoma tissue using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504717)
Anti-FXYD3 mouse monoclonal antibody (TA504717) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY FXYD3(RC213945).
Western blot analysis of extracts (35ug) from 9 different cell lines by usin g anti-FXYD3 monoclonal antibody (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FXYD3 (RC213945, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FXYD3.
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504726)
Immunohistochemical staining of paraffin-embedded Human colon tissue within the normal limits using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504726)
Immunohistochemical staining of paraffin-embedded Carcinoma of Human lung tissue using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504726)
Immunohistochemical staining of paraffin-embedded Human prostate tissue within the normal limits using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504726)
Immunohistochemical staining of paraffin-embedded Human endometrium tissue within the normal limits using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504726)
Immunohistochemical staining of paraffin-embedded Human tonsil within the normal limits using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504726)
Immunohistochemical staining of paraffin-embedded Carcinoma of Human prostate tissue using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504726)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504726)
Immunohistochemical staining of paraffin-embedded Carcinoma of Human bladder tissue using anti-FXYD3 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504726)
Anti-FXYD3 mouse monoclonal antibody (TA504726) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY FXYD3(RC213945).
Western blot analysis of extracts (35ug) from 9 different cell lines by usin g anti-FXYD3 monoclonal antibody (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FXYD3 (RC213945, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FXYD3.
- Quick-Filters:
- Highly Validated (3)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA504620 | FXYD3 antibody |
||||||
| FXYD3 mouse monoclonal antibody, clone OTI4E3 (formerly 4E3) | |||||||
 |
Mouse | IgG2a | OTI4E3 | Purified | Hu | ICC/IF, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
 +8 additional images |
Highly validated antibody!
|
||||||
| TA504717 | FXYD3 antibody |
||||||
| FXYD3 mouse monoclonal antibody, clone OTI1E8 (formerly 1E8) | |||||||
 |
Mouse | IgG1 | OTI1E8 | Purified | Hu | ICC/IF, P, WB |
0.1 ml /
€379.00
|
| OriGene Technologies, Inc. | |||||||
| +12 additional images |
Highly validated antibody!
|
||||||
| TA504726 | FXYD3 antibody |
||||||
| FXYD3 mouse monoclonal antibody, clone OTI1F12 (formerly 1F12) | |||||||
 |
Mouse | IgG2a | OTI1F12 | Purified | Hu | ICC/IF, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +11 additional images |
Highly validated antibody!
|
||||||
| TA504572 | FXYD3 antibody |
||||||
| FXYD3 mouse monoclonal antibody, clone OTI1A8 (formerly 1A8) | |||||||
 |
Mouse | IgG1 | OTI1A8 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA504594 | FXYD3 antibody |
||||||
| FXYD3 mouse monoclonal antibody, clone OTI2F7 (formerly 2F7) | |||||||
 |
Mouse | IgG1 | OTI2F7 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA504595 | FXYD3 antibody |
||||||
| FXYD3 mouse monoclonal antibody, clone OTI1G3 (formerly 1G3) | |||||||
 |
Mouse | IgG1 | OTI1G3 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA504610 | FXYD3 antibody |
||||||
| FXYD3 mouse monoclonal antibody, clone OTI1D1 (formerly 1D1) | |||||||
 |
Mouse | IgG2a | OTI1D1 | Purified | Hu | F, ICC/IF, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|
||||||
| TA504646 | FXYD3 antibody |
||||||
| FXYD3 mouse monoclonal antibody, clone OTI3D8 (formerly 3D8) | |||||||
 |
Mouse | IgG1 | OTI3D8 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP313945 | FXYD3 (transcript variant 1) |
||||
| Recombinant protein of human FXYD domain containing ion transport regulator 3 (FXYD3), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP327235 | FXYD3 (transcript variant 7) |
||||
| Recombinant protein of human FXYD domain containing ion transport regulator 3 (FXYD3), transcript variant 7 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP327269 | FXYD3 (transcript variant 8) |
||||
| Recombinant protein of human FXYD domain containing ion transport regulator 3 (FXYD3), transcript variant 8 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY411880 | FXYD3 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY416954 | FXYD3 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY427762 | FXYD3 overexpression lysate |
|
|
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. | ||
| LY427763 | FXYD3 overexpression lysate |
|
|
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. |